USP14 and cervical cancer: Here we demonstrated that IU1, as a pharmacological deubiquitinating enzyme USP14 selective inhibitor, dramatically decreased MDM2 expression, accompanied by blocking G0/G1 to S phase transition, reducing cell growth and triggering cell apoptosis in cervical cancer cells.